Search clinical trials for: RO7049665

Total 3 results

Hoffmann-La Roche

Terminated

Effect of RO7049665 on the Time to Relapse Following Steroid Tapering in Participants With Autoimmune Hepatitis (AIH)

Autoimmune Hepatitis | Autoimmune Chronic Hepatitis

Canada, United Kingdom, Korea, Republic of, Australia, Germany, Italy, Netherlands, Portugal
Hoffmann-La Roche

Terminated

Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)

Ulcerative Colitis

United States, Hungary, Georgia, Moldova, Republic of, Ukraine
Hoffmann-La Roche

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7049665 in Healthy Volunteers

Healthy Volunteers

Netherlands

3

Subscribe